VA Arlington의 대장직장암 임상 시험
대장직장암 관련 연구 52개가 Arlington 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Inova Fair Oaks Hospital, Fairfax · 11마일 거리
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
피험자 모집 중2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- NEXT Virginia, Fairfax · 11마일 거리
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
피험자 모집 중1/2상
- Inova Schar Cancer Institute, Fairfax · 11마일 거리
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
피험자 모집 중1상
- ALX Center 2, Fairfax · 11마일 거리
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · 11마일 거리
- Virginia Cancer Specialists, PC, Reston · 14마일 거리
- 외 1개
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
피험자 모집 중1/2상
- NEXT Oncology, Fairfax · 11마일 거리
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중2상
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · 11마일 거리
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
피험자 모집 중3상
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
피험자 모집 중3상
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · 11마일 거리
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
피험자 모집 중2/3상
- Local Institution - 0278, Fairfax · 11마일 거리
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
피험자 모집 중1/2상
- Next Oncology Virginia Cancer Specialist, Fairfax · 11마일 거리
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
피험자 모집 중1상
- NEXT - Virginia, Fairfax · 11마일 거리
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology, Fairfax · 11마일 거리
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
피험자 모집 중3상
- Clinical Study Site, Fairfax · 11마일 거리
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
피험자 모집 중2상
- Inova Schar Cancer, Fairfax · 11마일 거리
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
피험자 모집 중1상
- NEXT Oncology, Fairfax · 11마일 거리
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Clinical Trial Site, Fairfax · 11마일 거리
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Next Virginia, Fairfax · 11마일 거리
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
피험자 모집 중2상
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11마일 거리
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11마일 거리
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
피험자 모집 중1상
- NEXT Texas LLC - Virginia, Fairfax · 11마일 거리
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
피험자 모집 중1상
- Research Site, Fairfax · 11마일 거리
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
피험자 모집 중1상
- NEXT Oncology Virginia, Fairfax · 11마일 거리
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Next Oncology Virginia, Fairfax · 11마일 거리
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
피험자 모집 중1상
- NEXT Virginia, LLC, Fairfax · 11마일 거리
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
피험자 모집 중1/2상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Virginia, Fairfax · 11마일 거리
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- NEXT, Virginia, Fairfax · 11마일 거리
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Virginia, Fairfax · 11마일 거리
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
피험자 모집 중1상
- Virginia Cancer Specialists, Fairfax · 11마일 거리
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
피험자 모집 중1상
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11마일 거리
다른 도시의 대장직장암 시험
- Houston, TX연구 102개
- New York City, NY연구 78개
- Nashville, TN연구 69개
- Boston, MA연구 63개
- Los Angeles, CA연구 59개
- St. Louis, MO연구 50개
- San Antonio, TX연구 46개
- Philadelphia, PA연구 44개
- Grand Rapids, MI연구 40개
- Baldwin Park, CA연구 37개
- Chicago, IL연구 34개
- Tampa, FL연구 34개
Arlington의 다른 연구
- 비소세포폐암연구 104개
- 전이성 암연구 53개
- 암 (전체)연구 48개
- 유방암연구 47개
- 난소암연구 46개
- 폐암연구 41개
- 자궁내막암연구 39개
- 췌장암연구 33개
- 두경부 편평세포암연구 26개
- 소세포 폐암연구 23개
- 위암연구 20개
- 삼중음성 유방암연구 20개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.